Susceptible Young Adults and Development of Chronic Obstructive Pulmonary Disease Later in Life

被引:5
作者
Colak, Yunus [1 ,2 ,4 ]
Lange, Peter [1 ,2 ,5 ]
Vestbo, Jorgen [6 ]
Nordestgaard, Borge G. [2 ,3 ,4 ]
Afzal, Shoaib [2 ,4 ]
机构
[1] Copenhagen Univ Hosp, Dept Resp Med, Copenhagen, Denmark
[2] Copenhagen Gen Populat Study, Copenhagen, Denmark
[3] Copenhagen Univ Hosp Herlev & Gentofte, Dept Clin Biochem, Copenhagen, Denmark
[4] Univ Copenhagen, Dept Clin Med, Fac Hlth andMed Sci, Copenhagen, Denmark
[5] Univ Copenhagen, Epidemiol Sect, Dept Publ Hlth, Copenhagen, Denmark
[6] Univ Manchester, Manchester Acad Hlth Sci Ctr, Sch Biol Sci, Div Infect Immun & Resp Med, Manchester, Lancs, England
关键词
CHRONIC MUCUS HYPERSECRETION; POPULATION; DECLINE; COPD; INTERVENTION; INDIVIDUALS; PROGNOSIS; MORTALITY; FEV(1);
D O I
10.1164/rccm.202308-1452OC
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Rationale: Chronic obstructive pulmonary disease (COPD) has its origin in early life, and the Global Initiative for Chronic Obstructive Lung Disease (GOLD) proposes a predisease state termed "pre-COPD." Objectives: We tested the hypothesis that susceptible young adults identified with chronic bronchitis and subtle lung function impairment will develop COPD later in life. Methods: We followed random individuals without COPD ages 20-50 years from two population-based cohorts from different smoking eras-the Copenhagen General Population Study from 2003 (N= 5,497) and the Copenhagen City Heart Study from 1976-1978 (N= 2,609)-for 10 and 25 years, for the development of COPD (FEV1/FVC,0.70) and COPD GOLD Stages 2-4 (additionally, FEV1,80% predicted). Measurements and Main Results: After 10 years, 28% developed COPD and 13% developed COPD GOLD Stages 2- 4 in individuals susceptible to COPD, compared with 8% and 1% in those without any susceptibility to COPD. Correspondingly, after 25 years, 22% versus 13% developed COPD and 20% versus 8% developed COPD GOLD Stages 2-4. More than half of incident COPD cases developed from a susceptible state. Compared with those without susceptibility to COPD, multivariable-adjusted odds ratios in those susceptible to COPD were 3.42 (95% confidence interval: 2.78-4.21) for COPD and 10.1 (6.77-15.2) for COPD GOLD Stages 2-4 after 10 years and were 1.54 (1.23-1.93) and 2.12 (1.64-2.73) after 25 years. The ability of a COPD risk score- consisting of the state of susceptibility to COPD with smoking and asthma as risk factors-to predict COPD later in life was high. Conclusions: Our study suggests the existence of a predisease state of COPD, which can be used for early identification of susceptible individuals at risk for COPD later in life.
引用
收藏
页码:607 / 617
页数:11
相关论文
共 38 条
[1]   Diagnostic Instability and Reversals of Chronic Obstructive Pulmonary Disease Diagnosis in Individuals with Mild to Moderate Airflow Obstruction [J].
Aaron, Shawn D. ;
Tan, Wan C. ;
Bourbeau, Jean ;
Sin, Don D. ;
Loves, Robyn H. ;
MacNeil, Jenna ;
Whitmore, George A. .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 196 (03) :306-314
[2]   Update on the Pathogenesis of Chronic Obstructive Pulmonary Disease [J].
Agusti, Alvar ;
Hogg, James C. .
NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (13) :1248-1256
[3]   The Presence of Chronic Mucus Hypersecretion across Adult Life in Relation to Chronic Obstructive Pulmonary Disease Development [J].
Allinson, James P. ;
Hardy, Rebecca ;
Donaldson, Gavin C. ;
Shaheen, Seif O. ;
Kuh, Diana ;
Wedzicha, Jadwiga A. .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193 (06) :662-672
[4]  
[Anonymous], 2023, Global strategy for the. diagnosis, management, and prevention of chronic obstructive pulmonary disease
[5]   EFFECTS OF SMOKING INTERVENTION AND THE USE OF AN INHALED ANTICHOLINERGIC BRONCHODILATOR ON THE RATE OF DECLINE OF FEV(1) - THE LUNG HEALTH STUDY [J].
ANTHONISEN, NR ;
CONNETT, JE ;
KILEY, JP ;
ALTOSE, MD ;
BAILEY, WC ;
BUIST, AS ;
CONWAY, WA ;
ENRIGHT, PL ;
KANNER, RE ;
OHARA, P ;
OWENS, GR ;
SCANLON, PD ;
TASHKIN, DP ;
WISE, RA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 272 (19) :1497-1505
[6]   The effects of a smoking cessation intervention on 14.5-year mortality - A randomized clinical trial [J].
Anthonisen, NR ;
Skeans, MA ;
Wise, RA ;
Manfreda, J ;
Kanner, RE ;
Connett, JE .
ANNALS OF INTERNAL MEDICINE, 2005, 142 (04) :233-239
[7]   Reversible Airflow Obstruction Predicts Future Chronic Obstructive Pulmonary Disease Development in the SPIROMICS Cohort An Observational Cohort Study [J].
Buhr, Russell G. ;
Barjaktarevic, Igor Z. ;
Quibrera, P. Miguel ;
Bateman, Lori A. ;
Bleecker, Eugene R. ;
Couper, David J. ;
Curtis, Jeffrey L. ;
Dolezal, Brett A. ;
Han, MeiLan K. ;
Hansel, Nadia N. ;
Krishnan, Jerry A. ;
Martinez, Fernando J. ;
McKleroy, William ;
Paine, Robert, III ;
Rennard, Stephen, I ;
Tashkin, Donald P. ;
Woodruff, Prescott G. ;
Kanner, Richard E. ;
Cooper, Christopher B. .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 206 (05) :554-562
[8]   Pharmacotherapy and Lung Function Decline in Patients with Chronic Obstructive Pulmonary Disease A Systematic Review [J].
Celli, Bartolome R. ;
Anderson, Julie A. ;
Cowans, Nicholas J. ;
Crim, Courtney ;
Hartley, Benjamin F. ;
Martinez, Fernando J. ;
Morris, Andrea N. ;
Quasny, Holly ;
Yates, Julie ;
Vestbo, Jorgen ;
Calverley, Peter M. A. .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (06) :689-698
[9]   Pre-COPD in young adults and COPD later in life: A population-based cross-cohort comparison study [J].
Colak, Yunus ;
Lange, Peter ;
Vestbo, Jorgen ;
Nordestgaard, Borge G. ;
Afzal, Shoaib .
EUROPEAN RESPIRATORY JOURNAL, 2023, 62
[10]   Prognosis of Patients with Chronic Obstructive Pulmonary Disease Not Eligible for Major Clinical Trials [J].
Colak, Yunus ;
Nordestgaard, Borge G. ;
Lange, Peter ;
Vestbo, Jorgen ;
Afzal, Shoaib .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 206 (03) :271-280